Excellent news, recruitment has begun. A new CRO has also been appointed closely linked to Harvard Medical School.
This could be one incredible 12 month turnaround if management are able to pull this off.
After taking a close look at the new application, I am confident RAP can surpass its gravity defying heights it reached in late 2016.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Enrols First Patient in SMARTCOUGH-C-2 Study
Ann: ResApp Enrols First Patient in SMARTCOUGH-C-2 Study, page-3
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online